Skip to content
Biodatica
Start free

SciTech Development, Inc.

Scottsdale, Arizona

OncologyPhase I
Compare Sign in to watch

What changed

Study registered, no phase assigned: Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

6mo agoTrial registeredDec 30, 2025Source filing (opens the source filing in a new tab)

Momentum

70no change

Momentum 70 out of 100, unchanged since the last recompute.

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase I

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

517 pre-ticker oncology companies at Phase I

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Trial

    NA registered

    Mar 1, 2025

    Rehabilitation Program, Breast Cancer Patients · ENROLLING_BY_INVITATION · sponsor: José Manuel Afonso Moreira · Heart Pillow - Chemoteraphy

    ClinicalTrials.gov · NCT06986213 (opens the source filing in a new tab)

  2. Trial

    PHASE1 registered

    Dec 18, 2023

    T-cell Lymphoma, Cutaneous/Peripheral T-Cell Lymphoma, Peripheral T-cell Lymphoma, Peripheral T-Cell Lymphoma, Not Classified, Primary Cutaneous T-cell Lymphoma, Cutaneous T-Cell Lymphoma, Unspecified, Cutaneous T-cell Lymphoma, Follicular T-Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Sézary's Disease, Mycosis Fungoides · RECRUITING · sponsor: SciTech Development, Inc. · Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

    ClinicalTrials.gov · NCT04234048 (opens the source filing in a new tab)

  3. Trial

    Study registered

    Oct 1, 2004

    Cutaneous T-cell Lymphoma, Sezary Syndrome, Mycosis Fungoides, Eczema, Atopic Dermatitis · RECRUITING · sponsor: University of Pittsburgh · Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

    ClinicalTrials.gov · NCT00177268 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources